USE OF BELATACEPT AS RESCUE IN KIDNEY GRAFT RECIPIENTS WITH INTOLERANCE TO CALCINEURIN INHIBITORS: A FRENCH EXPERIENCE OF 36 CASES
THE IMPACT OF MTOR INHIBITION ON EVOLUTION OF RENAL FUNCTION AND URINARY PROTEIN EXCRETION - 24 MONTHS DATA FROM 719 DE NOVO LTX RECIPIENTS
CNI AND STEROID-FREE IMMUNOSUPPRESSION AFTER SPK TRANSPLANTATION: ONE YEAR RESULTS OF A PROSPECTIVE AND RANDOMIZED STUDY
EPITHELIAL TO MESENCHYMAL TRANSITION MARKERS IN KIDNEY TRANSPLANT RECIPIENTS: THE CERTITEM TRIAL
RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
LONG-TERM EXPOSURE TO BELATACEPT IN RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS
LONG-TERM BELATACEPT MAINTAINS EFFICACY AND SAFETY: 5-YEAR BENEFIT LONG-TERM EXTENSION (LTE) RESULTS
MTOR INHIBITORS THERAPY AFTER LIVER TRANSPLANTATION ALLOWS A SUSTAINED INCREASED IN REGULATORY T CELLS PRESERVING THEIR SUPPRESSIVE CAPACITY
CNI FREE IMMUNOSUPPRESSION IN HEART TRANSPLANT PATIENTS TREATED WITH EVEROLIMUS: RESULTS OF A MULTICENTER FRENCH REGISTRY
EFFECT OF ECULIZUMAB ON THE FIBRINOLYTIC ACTIVITY OF MICROVESICLES IN A RECURRENCE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME AFTER RENAL TRANSPLANTATION
EVALUATION OF REGULATORY T CELLS IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION
IL-4 AND IL-13 OVER-EXPRESSION IN SEVERE RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION
IL-22 DEFICIENCY IN DONOR T CELLS ATTENUATES MURINE ACUTE GRAFT-VERSUS-HOST DISEASE MORTALITY WHILE SPARING THE GRAFT-VERSUSLEUKEMIA EFFECT
INCREASE SURVIVAL OF ALLOGENEIC SKIN GRAFT IN MICE BY TREATMENT WITH LOW-DOSE IL-2 COMBINED WITH RAPAMYCIN
EFFECT OF MELATONIN ON THE ENDOPLASMIC RETICULUM STRESS AND THE AKT PATHWAY ASSOCIATED WITH RENAL ISCHEMIA REPERFUSION: ROLE OF AMPK
PRODUCTION OF ANTI-HLA ANTIBODIES INDEPENDENT OF CD4 + T CELLS IN ORGAN TRANSPLANTATION
INVOLVEMENT OF TGFβ/IDO PATHWAY IN B CELL REGULATION MECHANISMS: APPLICATION TO CHRONIC HUMORAL REJECTION OF RENAL ALLOGRAFT
GAMMA-DELTA T CELLS IN CELLULAR STRESS SURVEILLANCE IN TRANSPLANTATION
VERY LATE-ONSET CYTOMEGALOVIRUS DNAEMIA IN ASYMPTOMATIC RECIPIENTS: INCIDENCE, RISK FACTORS AND OUTCOME
MICROSPORIDIOSIS IN RENAL TRANSPLANT RECIPIENTS
MICAFUNGIN AS ANTIFUNGAL PROPHYLAXIS IN HIGHRISK LIVER TRANSPLANTATION: RANDOMISED, MULTICENTRE TRIAL
PREDICT THE EVOLUTION OF CMV INFECTION: A MODEL BASED ON GAMMA-DELTA T CELL KINETICS
NAÏVE AND TEMRA VD2NEG GD T CELL SUBSETS DURING POST-TRANSPLANT CMV DNAEMIA: A PILOT STUDY
IS MYCOPHENOLATE ACID EXPOSURE A RISK FACTOR FOR BK VIRUS INFECTION?
RISK FACTORS FOR SIGNIFICANT BK VIRURIA DURING EARLY POST-TRANSPLANT PERIOD
SHOULD WE TRANSPLANT OR DIALYZE HIV-INFECTED PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE V?
PTLD RENAL TRANSPLANT PATIENTS DIE FROM CHEMOTHERAPY-INDUCED INFECTIOUS COMPLICATIONS RATHER THAN FROM LYMPHOMA PROGRESSION: A SINGLE CENTER STUDY
NORMALIZATION OF URINARY CELL MRNA LEVELS FOR DIAGNOSIS OF TCMR IN RENAL TRANSPLANTATION
ECULIZUMAB IN ANTIBODY MEDIATED REJECTION
THE PROGNOSTIC FACTORS IN CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION
MANAGEMENT OF SENSITIZED PATIENTS IN KIDNEY TRANSPLANTATION. PROSPECTIVE SINGLE CENTER STRATEGY
EVALUATION OF THE EFFICACY AND SAFETY OF BASILIXIMAB AS CURATIVE TREATMENT OF PERSISTENT OR COMPLICATED ACUTE REJECTION IN CARDIAC TRANSPLANTATION
EARLY ACUTE HUMORAL REJECTION IN THE ABSENCE OF ANTI-HLA ANTIBODIES: CLINICO-PATHOLOGICAL DESCRIPTION FROM A FRENCH NATION-WIDE STUDY
EVALUATION OF THE TREATMENT's EFFICACY OF ACUTE-MEDIATED REJECTION BY THE ASSOCIATION PP/IVIG/RITUXIMAB, IN KIDNEY TRANSPLANTATION
CORTICOSTEROID AVOIDANCE IN ADULT KIDNEY TRANSPLANT RECIPIENTS RECEIVING ATG-F: 5 YEARS RESULTS OF A PROSPECTIVE AND RANDOMIZED STUDY
UNCONTROLLED PATHWAYS ACTIVATION AFTER RENAL TRANSPLANTATION AND C5B9 DEPOSITS ON GRAFT PREDICT GRAFT OUTCOME IN ADULT RENAL TRANSPLANT WITH C3 GLOMERULOPATHY
ANALYSIS OF RENAL GRAFT ELASTOGRAPHY DOESN'T ALLOW FOR DETERMINATION OF INTERSTITIAL FIBROSIS
SURVIVAL AND POST TRANSPLANT COMPLICATIONS OF OBESE RENAL TRANSPLANT RECIPIENTS
EVALUATION OF THE MORBI-MORTALITY OF LIVER TRANSPLANT PATIENTS AT UNIVERSITY HOSPITAL OF LILLE. AN OBSERVATIONAL MONOCENTRIC RETROSPECTIVE STUDY
LIVER RETRANSPLANTATION IN ADULTS: 25 YEARS EXPERIENCE IN A EUROPEANCENTER
PROGNOSTIC FACTORS OF LONG-TERM SURVIVAL AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
PROGNOSTIC VALUE OF PROTOCOL GRAFT BIOPSY AT 3 MONTHS POST-GRAFT IN RENAL TRANSPLANTATION
IMPROVEMENT OF SENSORY NERVE CONDUCTION CORRELATES WITH CGMS MEAN GLUCOSE AND VARIABILITY REDUCTION FIVE YEARS AFTER ISLET TRANSPLANTATION FOR TYPE 1 DIABETES
OUTCOME OF ARISTOLOCHIC ACID NEPHROPATHY AFTER RENAL TRANSPLANTATION
LONG-TERM IMPACT OF SYMPTOMATIC VESICOURETERAL RELFUX AFTER KIDNEY TRANSPLANTATION: RESULTS FROM A RETROSPECTIVE MONOCENTRIC STUDY
RECOMBINANT C1 INHIBITOR LIMITS ISCHEMIA REPERFUSION INJURY AND IMPROVES GRAFT OUTCOMES IN A PIG MODEL OF KIDNEY TRANSPLANTATION
EFFECT OF ISCHEMIA-REPERFUSION ON RENAL CORTEX VASCULAR NETWORK IN A PORCINE RENAL AUTOTRANSPLANTATION MODEL
SIRT1 PROTECTS THE LIVER AGAINST ISCHEMIA REPERFUSION INJURY: IMPLICATIONS IN STEATOTIC LIVER ISCHEMIC PRECONDITIONING
RELEVANCE OF CARBONIC ANHYDRASE II IN RAT FATTY LIVER PRESERVATION
RESULTS IN LIVING DONOR FOR HEPATIC TRANSPLANTATION
OUTCOME OF THE DONOR LIVING IN KIDNEY TRANSPLANT: EXPERIENCE OF THE DEPARTMENT OF NEPHROLOGY CASABLANCA
RESULTS OF 64 LIVER TRANSPLANTATIONS WITH ELDERLY DONORS IN BORDEAUX
RESULTS OF TRANSPLANTATION WITH KIDNEYS FROM UNCONTROLLED NON-HEART-BEATING DONORS. A FRENCH EXPERIENCE IN PAYS DE LA LOIRE
THE DGFS: A USEFUL SCORING SYSTEM FOR THE PREDICTION AND MANAGEMENT OF DELAYED GRAFT FUNCTION FOLLOWING KIDNEY TRANSPLANTATION FROM CADAVERIC DONORS
FUNGAL CONTAMINATION OF TRANSPLANT-ORGAN PRESERVATION FLUID: ANALYSIS OF 12 NEW CASES IN THREE TRANSPLANT-CENTERS
CAN WE OPTIMIZE THE ORGAN PROCUREMENT ORGANISATION IN FRANCE?
KIDNEY DONATION: THE OPINION OF MOROCCANS
KNOWLEDGE AND ATTITUDES OF MOROCCAN STUDENTS ABOUT ORGAN DONATION AND TRANSPLANTATION
PERCEPTION OF ORGANS REMOVAL FROM BRAINDEAD PATIENTS BY ANESTHESIOLOGISTS IN CHU IBN ROCHD CASABLANCA
PROCUREMENT OF CORNEAS: ROLE OF HOSPITAL COORDINATION
THE EPIDEMIOLOGICAL PROFILE OF BRAIN DEATH KIDNEY DONOR AT THE UNIVERSITY HOSPITAL OF CASABLANCA
KIDNEY TRANSPLANTATION: HEMODIALYSIS AND ITS SURROUNDING ARE THEY INFORMED ENOUGH?
PREVALENCE, INCIDENCE, AND RISK FACTORS FOR DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN MAINTENANCE LIVER-TRANSPLANT PATIENTS
PRESENCE OF C3D FIXING HLA ANTIBODIES CARRY WORSE PROGNOSIS AND IS ASSOCIATED WITH INCREASED ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT (HT) PATIENTS
EVOLUTION AND IMPACT OF PRE-EXISTING DONOR SPECIFIC ANTIBODIES IN A MONOCENTRIC COHORT OF ADULT KIDNEY TRANSPLANT RECIPIENTS
ANTI HLA-CW AND ANTI HLA-DP DSA ARE PATHOGENIC IN KIDNEY TRANSPLANTATION
DE NOVO DONOR SPECIFIC HLA ANTIBODIES IN NON-SENSITIZED KIDNEY TRANSPLANT RECIPIENTS AFTER T-CELL MEDIATED REJECTION: A LONGITUDINAL COHORT ANALYSIS
C1Q FIXING ABILITY OF DE NOVO DONOR SPECIFIC ANTIBODIES PREDICTS EARLY BUT NOT LONG-TERM KIDNEY ALLOGRAFT LOSS
AUTOANTIBODY MONITORING IN THE FOLLOW-UP OF PANCREAS TRANSPLANT RECIPIENTS
INCIDENCE AND COMPLICATIONS OF DE NOVO DSAS AFTER ABO COMPATIBLE LIVER TRANSPLANTATION
IMPACT OF RENAL GRAFT NEPHRECTOMY ON SECOND KIDNEY TRANSPLANTATION SURVIVAL
THE OUTCOME OF PATIENTS RETURNED TO DIALYSIS AFTER KIDNEY TRANSPLANT FAILURE
RETROSPECTIVE STUDY COMPARING URETEROVESICAL AND PYELOURETERAL ANASTOMOSIS PERFORMED DURING KIDNEY TRANSPLANTATION COMING FROM EXTENDED CRITERIA DONORS
PRETAGREF STUDY. PREVALENCE OF TOBACCO USE AND FACTORS ASSOCIATED WITH SMOKING CESSATION IN KIDNEY TRANSPLANT RECIPIENTS
VITAMIN D DEFICIENCY AS A NOVEL RISK FACTOR OF NODAT
ROTATIONAL THROMBOELASTOMETRY FOR MANAGEMENT OF BLEEDING AND TRANSFUSION DURING LIVER TRANSPLANTATION: NOT BETTER THAN A TRAINED TEAM?
INFLUENCE OF RECIPIENT CYTOCHROME P450 3A5 POLYMORPHISM ON THE METABOLISM OF ADVAGRAF ADMINISTERED DE NOVO AFTER RENAL TRANSPLANTATION
IMPAIRED RESPONSE TO CLOPIDOGREL IN PATIENT WITH KIDNEY TRANSPLANTATION
RESULTS OF ROBOTIC PROSTATECTOMY AFTER KIDNEY TRANSPLANTATION
PREGNANCY AND KIDNEY TRANSPLANT
NEGATIVE ASSOCIATION OF BLOOD ANTICARDIOLIPIDS ANTIBODIES DETECTION BEFORE RENAL TRANSPLANT AND KIDNEY ALLOGRAFT FUNCTION: A COHORT STUDY
PREVALENCE OF DONOR SPECIFIC ANTIBODIES IN LIVER TRANSPLANT RECIPIENTS WITH UNEXPLAINED LIVER GRAFT ABNORMALITIES IS EXTREMELY HIGH AND SIGNIFICANTLY HIGHER THAN IN CONTROL GROUPS: ROLE OF ANTIBODY-MEDIATED REJECTION IN LONG TERM GRAFT DYSFONCTIONS
IDENTIFICATION AND CONSEQUENCES OF ANTIBODIES WHICH BOUND C1Q IN 118 KIDNEY TRANSPLANT RECIPIENTS WITH DONOR SPECIFIC ANTIBODIES
DONOR-SPECIFIC ANTIBODIES AGAINST DENATURED HLA CLASS I: DESCRIPTION, INCIDENCE, AND CLINICAL IMPACT
ANTIBODY-MEDIATED REJECTION IN ABO INCOMPATIBLE AND POSITIVE CROSSMATCH TRANSPLANTATIONS: A SIMILAR PHENOTYPE BUT A DIFFERENT OUTCOME
OUTCOME OF EARLY ANTIBODY-MEDIATED HISTOLOGIC LESIONS IN BLOOD GROUPINCOMPATIBLE KIDNEY TRANSPLANTATION
THREE-YEARS OUTCOMES AFTER SWITCHING TO BELATACEPT FROM CALCINEURIN INHIBITOR IN STABLE KIDNEY TRANSPLANT RECIPIENTS
INITIATION OF ONCE DAILY FORMULATION OF TACROLIMUS (TAC-OD) IN KIDNEY AND LIVER TRANSPLANT RECIPIENTS: 3 MONTH-INTERIM ANALYSIS OF A FRENCH MULTICENTER OBSERVATIONAL STUDY
RITUX-ERAH: MULTICENTER RANDOMIZED TRIAL OF RITUXIMAB ON ACUTE ANTIBODY MEDIATED REJECTION IN TRANSPLANTATION
NOROVIRUS DIARRHEA IN RENAL TRANSPLANT RECIPIENTS
INHIBITION OF ALLO-IMMUNE RESPONSE IN HUMAN AFTER EXPOSURE OF T LYMPHOCYTES TO ALLOGENEIC APOPTOTIC CELLS
IMPACT OF LATE MYCOPHENOLIC ACID EXPOSURE ON GRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS
CLINICAL PHARMACIST (CP) AND MEDICATION RECONCILIATION (MR) IN KIDNEY TRANSPLANTATION
THE TRANSFORM TRIAL DESIGN: A LARGE RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITORS IN DE NOVO RENAL TRANSPLANTATION
IMPACT OF ANOREXIA NERVOSA ON THE RESULTS AT FIVE YEARS IN KIDNEY TRANSPLANTATION
LATE CD4+ LYMPHOPENIA IN KIDNEY TRANSPLANT RECIPIENTS
EARLY ISCHEMIC PRECONDITIONING PROTECTS RAT KIDNEY AGAINST ISCHEMIA REPERFUSION INJURY VIA THE AKT/ENOS/HIF-1 ALPHA PATHWAY
EVALUATION OF PERIODONTAL STATUS IN RENAL TRANSPLANT PATIENT: CASE-CONTROL STUDY
THE NOCARDIOSIS IN A RENAL TRANSPLANT ABOUT EIGHT CASES
SEROPREVALENCE/SEROCONVERSION OF THE VHE IN POST RENAL TRANSPLANTATION AFTER PLASMATIC EXCHANGE
FATAL HUMAN HERPESVIRUS-6 INFECTION 5 MONTHS AFTER RENAL TRANSPLANTATION
DO IMMIGRANT HAVE DIFFERENT KIDNEY TRANSPLANTATION OUTCOMES OR HARDER ACCESS TO WAITING LIST, IN FRANCE?
BAFF POLYMORPHISMS AND SERUM LEVELS OF BAFF IN TUNISIAN KIDNEY TRANSPLANTATION
IVIG NEPHROTOXICITY IN KIDNEY TRANSPLANTATION
KIDNEY TRANSPLANTATION UNDER LOCAL ANESTHESIA: IS IT POSSIBLE ?
CENTRAL PRESSURE ASSESSMENT IN RENAL TRANSPLANT REICPIENTS
POORLY DIFFERENTIATED ADENOCARCINOMA OF THE RENAL GRAFT
RECURRENCE OF SCLEROSIS RENAL CRISIS IN A KIDNEY TRANSPLANT RECIPIENT
FACE TRANSPLANTATION WITH COMBINED HEMATOPOIETIC STEM CELL INFUSION AND VASCULARIZED BONE MARROW TRANSPLANTATION IS NOT ASSOCIATED WITH MIXED CHIMERISM IN HUMANS
NEPHRECTOMY FROM LIVING DONOR: WHICH TECHNIQUE TO CHOOSE?
ORGAN AND TISSUES DONATION AND HARVESTING FROM BRAIN STEM DEATH. SURVEY REALIZED BY MEDICAL STUDENTS
FACTORS ASSOCIATED WITH URINARY TRACT INFECTIONS (UTI) IN ENTEROBACTERIACEAE PRODUCING BETA -LACTAMASES WITH EXTENDED SPECTRUM (ESBLE): CASE-CONTROL STUDY IN RENAL TRANSPLANT PATIENTS BETWEEN 2008 AND 2012 AT THE UNIVERSITY HOSPITAL OF NANTES
ASSESSMENT OF CYTOMEGALOVIRUS SPECIFIC MEMORY T CELLS IN RENAL TRANSPLANT AND CORRELATION WITH VIRAL INFECTION
ACQUISITION OF EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING ENTEROBACTERIA DURING THE FIRST MONTHS OF RENAL TRANSPLANTATION: EPIDEMIOLOGY AND CLINICAL IMPACT
LATE CYTOMEGALOVIRUS (CMV) INFECTION IN RENAL TRANSPLANT RECIPIENTS: CLINICAL PRESENTATION AND RISK FACTORS: A CASE-CONTROL STUDY
EFFECT OF CYP3A5 POLYMORPHISM ON TACROLIMUS DOSE AND BLOOD LEVELS IN RENAL TRANSPLANTATION IN CLINICAL PRACTICE
LOOKING FOR CYCLOSPORINE AUC TARGETS IN RENAL TRANSPLANTATION
SYSTEMATIC SCREENING OF INTRACRANIAL CEREBRAL ANEURYSM IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE BEFORE RENAL TRANSPLANTATION: RETROSPECTIVE ANALYSIS ABOUT 116 PATIENTS
ANALYSIS OF ROUTINE DOSE ADJUSTMENTS OF SIROLIMUS IN HEPATIC TRANSPLANT PATIENTS
EFFICACY AND SAFETY OF PERITONEAL DIALYSIS IN RENAL TRANSPLANT PATIENTS FROM NON-HEART BEATING DONOR REQUIRING RENAL REPLACEMENT THERAPY IN THE IMMEDIATE POST-GRAFT PERIOD
EFFICACY AND SAFETY OF GASTRIC BALLOON IN OBESE PATIENTS CANDIDATES TO RENAL TRANSPLANTATION
IVIG IN KIDNEY AND HEART TRANSPLANTATION: A FRENCH NATIONAL SURVEY